{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:43:49Z","timestamp":1792885429435,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100024031","name":"Agency for Healthcare Research and Quality Safety Program for Telemedicine","doi-asserted-by":"publisher","award":["K12HS026396-03"],"award-info":[{"award-number":["K12HS026396-03"]}],"id":[{"id":"10.13039\/100024031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA051807"],"award-info":[{"award-number":["K24DA051807"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite rising hospitalizations for opioid use disorder (OUD), rates of inpatient medications for OUD (MOUD) initiation are low. Addiction consult services (ACSs) facilitate inpatient MOUD initiation and linkage to post-discharge MOUD, but few studies have rigorously examined ACS OUD outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the association between ACS consultation and inpatient MOUD initiation, discharge MOUD provision, and post-discharge MOUD linkage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective study comparing admissions that received an ACS consult and propensity score\u2013matched historical control admissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects<\/jats:title>\n                    <jats:p>One hundred admissions with an OUD-related diagnosis, of patients not currently receiving MOUD who received an ACS consult, and 100 matched historical controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Consultation from an interprofessional ACS offering expertise in MOUD initiation and linkage to post-discharge MOUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Measures<\/jats:title>\n                    <jats:p>The primary outcome was inpatient MOUD initiation (methadone or buprenorphine). Secondary outcomes were inpatient buprenorphine initiation, inpatient methadone initiation, discharge prescription for buprenorphine, linkage to post-discharge MOUD (buprenorphine prescription within 60\u00a0days and new methadone administration at a methadone program within 30\u00a0days after discharge), patient-directed discharge, 30-day readmission, and 30-day emergency department (ED) visit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      Among 200 admissions with an OUD-related diagnosis, those that received an ACS consultation were significantly more likely to have inpatient MOUD initiation (OR 2.57 [CI 1.44\u20134.61]), inpatient buprenorphine initiation (OR 5.50 [2.14\u201314.15]), a discharge prescription for buprenorphine (OR 17.22 [3.94\u201375.13]), a buprenorphine prescription within 60\u00a0days (22.0% vs. 0.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; of those with inpatient buprenorphine initiation: 84.6% vs. 0.0%), and new methadone administration at a methadone program within 30\u00a0days after discharge (7.0% vs. 0.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007; of those with inpatient methadone initiation: 19.4% vs. 0.0%). There were no significant differences in other secondary outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There was a strong association between ACS consultation and inpatient MOUD initiation and linkage to post-discharge MOUD. ACSs promote the delivery of evidence-based care for patients with OUD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-024-08837-0","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T11:05:38Z","timestamp":1723547138000},"page":"2961-2969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Addiction Consult Service and Inpatient Outcomes Among Patients with OUD"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-5589","authenticated-orcid":false,"given":"Andrea","family":"Jakubowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Singh\u2011Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Torres\u2011Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Southern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Nahvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"8837_CR1","unstructured":"Overdose Death Rates | National Institute on Drug Abuse (NIDA). Published 2023. Accessed December 12, 2018. https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates."},{"key":"8837_CR2","doi-asserted-by":"publisher","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2014(2). https:\/\/doi.org\/10.1002\/14651858.CD002207.pub4.","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"8837_CR3","doi-asserted-by":"publisher","unstructured":"Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. Published online April 26, 2017:j1550. https:\/\/doi.org\/10.1136\/bmj.j1550.","DOI":"10.1136\/bmj.j1550"},{"issue":"1","key":"8837_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/infdis\/jir196","volume":"204","author":"H Hagan","year":"2011","unstructured":"Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204(1):74-83. https:\/\/doi.org\/10.1093\/infdis\/jir196.","journal-title":"J Infect Dis."},{"issue":"3","key":"8837_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","volume":"66","author":"GE Woody","year":"2014","unstructured":"Woody GE, Bruce D, Korthuis PT, et al. HIV risk reduction with buprenorphine-naloxone or methadone: Findings from a randomized trial. J Acquir Immune Defic Syndr (1988). 2014;66(3):288-293. https:\/\/doi.org\/10.1097\/QAI.0000000000000165.","journal-title":"J Acquir Immune Defic Syndr (1988)"},{"issue":"12","key":"8837_CR6","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1111\/add.15959","volume":"117","author":"M Burns","year":"2022","unstructured":"Burns M, Tang L, Chang CCH, et al. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study. Addiction. 2022;117(12):3079-3088. https:\/\/doi.org\/10.1111\/add.15959.","journal-title":"Addiction."},{"issue":"6","key":"8837_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","volume":"10","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Clark B, Macpherson G, et al. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. Lancet Psychiatry. 2023;10(6):386-402. https:\/\/doi.org\/10.1016\/S2215-0366(23)00095-0.","journal-title":"Lancet Psychiatry."},{"issue":"14","key":"8837_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1001\/jama.2015.10345","volume":"314","author":"B Saloner","year":"2015","unstructured":"Saloner B, Karthikeyan S. Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013. JAMA. 2015;314(14):1515-1517. https:\/\/doi.org\/10.1001\/jama.2015.10345.","journal-title":"JAMA"},{"issue":"2","key":"8837_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0229174","volume":"15","author":"JA Singh","year":"2020","unstructured":"Singh JA, Cleveland JD. National U.S. Time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality. PLoS One. 2020;15(2):1-14. https:\/\/doi.org\/10.1371\/journal.pone.0229174.","journal-title":"PLoS One."},{"issue":"2","key":"8837_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, et al. Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175-181. https:\/\/doi.org\/10.2105\/AJPH.2017.304132.","journal-title":"Am J Public Health."},{"key":"8837_CR11","unstructured":"Weiss AJ, Heslin KC, Stocks C, Owens PL. Hospital Inpatient Stays Related to Opioid Use Disorder and Endocarditis, 2016. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Published online April 14, 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557173\/. Accessed 17 September 2021."},{"key":"8837_CR12","unstructured":"National Center for Health Statistics. Drug Overdose-Associated Hospital Encounters Involving Selected Drugs by Month from Selected Hospitals. Drug use hospital data. Published May 2023. https:\/\/www.cdc.gov\/nchs\/dhcs\/drug-use\/drug-overdose.htm. Accessed 1 February 2024."},{"issue":"3","key":"8837_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.12788\/jhm.3311","volume":"15","author":"H Englander","year":"2020","unstructured":"Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A call to action: Hospitalists\u2019 role in addressing substance use disorder. J Hosp Med. 2020;15(3):184-187. https:\/\/doi.org\/10.12788\/jhm.3311.","journal-title":"J Hosp Med."},{"key":"8837_CR14","doi-asserted-by":"publisher","unstructured":"Kendall CE, Boucher LM, Donelle J, et al. Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Serv Res. 2020;20(1). https:\/\/doi.org\/10.1186\/s12913-020-05670-z.","DOI":"10.1186\/s12913-020-05670-z"},{"key":"8837_CR15","doi-asserted-by":"publisher","unstructured":"Armoon B, Griffiths MD, Mohammadi R, Ahounbar E, Fleury MJ. Acute care utilization and its associated determinants among patients with substance-related disorders: A worldwide systematic review and meta-analysis. J Psychiatr Ment Health Nurs. Published online 2023. https:\/\/doi.org\/10.1111\/jpm.12936.","DOI":"10.1111\/jpm.12936"},{"key":"8837_CR16","doi-asserted-by":"publisher","unstructured":"Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus. 2020;41(4). https:\/\/doi.org\/10.1080\/08897077.2019.1671942.","DOI":"10.1080\/08897077.2019.1671942"},{"issue":"8","key":"8837_CR17","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: A randomized clinical trial. JAMA Intern Med. 2014;174(8):1369-1376. https:\/\/doi.org\/10.1001\/jamainternmed.2014.2556.","journal-title":"JAMA Intern Med."},{"issue":"8","key":"8837_CR18","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s11606-020-05815-0","volume":"35","author":"KC Priest","year":"2020","unstructured":"Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis. J Gen Intern Med. 2020;35(8):2365-2374. https:\/\/doi.org\/10.1007\/s11606-020-05815-0.","journal-title":"J Gen Intern Med."},{"key":"8837_CR19","doi-asserted-by":"publisher","unstructured":"Kilaru AS, Kilaru AS, Xiong A, et al. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3(5). https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.5852.","DOI":"10.1001\/jamanetworkopen.2020.5852"},{"key":"8837_CR20","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences E and M. Medications for Opioid Use Disorder Save Lives. In: Leshner AI, Mancher M, eds. National Academies Press; 2019. https:\/\/doi.org\/10.17226\/25310.","DOI":"10.17226\/25310"},{"issue":"1","key":"8837_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13722-023-00386-x","volume":"18","author":"A Jakubowski","year":"2023","unstructured":"Jakubowski A, Singh-Tan S, Torres-Lockhart K, et al. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract. 2023;18(1):31. https:\/\/doi.org\/10.1186\/s13722-023-00386-x.","journal-title":"Addict Sci Clin Pract."},{"issue":"1","key":"8837_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08897077.2020.1748169","volume":"43","author":"SL Calcaterra","year":"2022","unstructured":"Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O\u2019Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: a survey of hospitalist physicians. Subst Abus. 2022;43(1):143-151. https:\/\/doi.org\/10.1080\/08897077.2020.1748169.","journal-title":"Subst Abus."},{"issue":"1","key":"8837_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/08897077.2021.1949663","volume":"43","author":"R French","year":"2022","unstructured":"French R, Aronowitz SV, Brooks Carthon JM, Schmidt HD, Compton P. Interventions for hospitalized medical and surgical patients with opioid use disorder: A systematic review. Subst Abus. 2022;43(1):495-507. https:\/\/doi.org\/10.1080\/08897077.2021.1949663.","journal-title":"Subst Abus."},{"key":"8837_CR24","unstructured":"Montefiore Medical Center Office of Community and Population Health. Community Health Needs Assessment and Implementation Strategy Report. 2019."},{"key":"8837_CR25","unstructured":"New York State Opioid Annual Data Report 2022 New York State Department of Health. 2022."},{"key":"8837_CR26","unstructured":"Tuazon E, Bauman M, Sun T, et al. Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2022. New York City Department of Health and Mental Hygiene: Epi Data Brief (137); September 2023."},{"key":"8837_CR27","unstructured":"OASAS. OASAS Provider and Program Search. https:\/\/webapps.oasas.ny.gov\/providerDirectory\/index.cfm#search_results. Accessed 3 January 2024."},{"key":"8837_CR28","doi-asserted-by":"publisher","unstructured":"Khalid L, Cunningham CO, Deng Y, et al. Cascade of care for office-based buprenorphine treatment in Bronx community clinics. J Subst Abuse Treat. 2022;139. https:\/\/doi.org\/10.1016\/j.jsat.2022.108778.","DOI":"10.1016\/j.jsat.2022.108778"},{"issue":"11","key":"8837_CR29","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1007\/s11606-022-07618-x","volume":"37","author":"H Englander","year":"2022","unstructured":"Englander H, Jones A, Krawczyk N, et al. A taxonomy of hospital-based addiction care models: a scoping review and key informant interviews. J Gen Intern Med. 2022;37(11):2821-2833. https:\/\/doi.org\/10.1007\/s11606-022-07618-x.","journal-title":"J Gen Intern Med."},{"issue":"4","key":"8837_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jac5.1591","volume":"5","author":"D Medaglio","year":"2022","unstructured":"Medaglio D, Stephens-Shields AJ, Leonard CE. Research and scholarly methods: Propensity scores. JACCP J Am Coll Clin Pharm. 2022;5(4):467-475. https:\/\/doi.org\/10.1002\/jac5.1591.","journal-title":"JACCP J Am Coll Clin Pharm."},{"key":"8837_CR31","doi-asserted-by":"publisher","unstructured":"Vandenbroucke JP, Von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. PLoS Medicine | www. 2007;4. https:\/\/doi.org\/10.1371\/journal.pmed.","DOI":"10.1371\/journal.pmed"},{"issue":"4","key":"8837_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/ADM.0000000000000931","volume":"16","author":"E Ajazi","year":"2021","unstructured":"Ajazi E, Dasgupta N, Marshall SW, et al. Revisiting the X BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis. J Addict Med. 2021;16(4):440-446. https:\/\/doi.org\/10.1097\/ADM.0000000000000931.","journal-title":"J Addict Med."},{"key":"8837_CR33","doi-asserted-by":"publisher","unstructured":"Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Published online 2019. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.031.","DOI":"10.1016\/j.drugalcdep.2019.02.031"},{"issue":"1","key":"8837_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ajad.12161","volume":"24","author":"J Suzuki","year":"2015","unstructured":"Suzuki J, Devido J, Kalra I, et al. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2015;24(1):10-14. https:\/\/doi.org\/10.1111\/ajad.12161.","journal-title":"Am J Addict."},{"issue":"1","key":"8837_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother Psychosom. 2022;91(1):8-35. https:\/\/doi.org\/10.1159\/000521288.","journal-title":"Psychother Psychosom."},{"issue":"11","key":"8837_CR36","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/cid\/ciy924","volume":"68","author":"LR Marks","year":"2019","unstructured":"Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2019;68(11):1935-1937. https:\/\/doi.org\/10.1093\/cid\/ciy924.","journal-title":"Clin Infect Dis."},{"key":"8837_CR37","doi-asserted-by":"publisher","unstructured":"Ray V, Waite MR, Spexarth FC, et al. Addiction management in hospitalized patients with intravenous drug use-associated infective endocarditis. Psychosomatics. 2020;61:678-687. https:\/\/doi.org\/10.1016\/j.psym.2020.06.019.","DOI":"10.1016\/j.psym.2020.06.019"},{"key":"8837_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JSAT.2017.05.007","volume":"79","author":"P Trowbridge","year":"2017","unstructured":"Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services \u2013 Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1. https:\/\/doi.org\/10.1016\/J.JSAT.2017.05.007.","journal-title":"J Subst Abuse Treat."},{"issue":"June","key":"8837_CR39","doi-asserted-by":"publisher","first-page":"108253","DOI":"10.1016\/j.drugalcdep.2020.108253","volume":"215","author":"EP Bhatraju","year":"2020","unstructured":"Bhatraju EP, Ludwig-Barron N, Takagi-Stewart J, Sandhu HK, Klein JW, Tsui JI. Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma. Drug Alcohol Depend. 2020;215(June):108253. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108253.","journal-title":"Drug Alcohol Depend."},{"key":"8837_CR40","doi-asserted-by":"publisher","unstructured":"Thompson HM, Faig W, VanKim NA, Sharma B, Afshar M, Karnik NS. Differences in length of stay and discharge destination among patients with substance use disorders: The effect of Substance Use Intervention Team (SUIT) consultation service. PLoS One. 2020;15(10 October). https:\/\/doi.org\/10.1371\/journal.pone.0239761.","DOI":"10.1371\/journal.pone.0239761"},{"issue":"8","key":"8837_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","volume":"32","author":"SE Wakeman","year":"2017","unstructured":"Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909-916. https:\/\/doi.org\/10.1007\/s11606-017-4077-z.","journal-title":"J Gen Intern Med."},{"issue":"7","key":"8837_CR42","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s11606-020-05966-0","volume":"36","author":"SE Wakeman","year":"2021","unstructured":"Wakeman SE, Kane M, Powell E, Howard S, Shaw C, Regan S. Impact of inpatient addiction consultation on hospital readmission. J Gen Intern Med. 2021;36(7):2161-2163. https:\/\/doi.org\/10.1007\/s11606-020-05966-0.","journal-title":"J Gen Intern Med."},{"key":"8837_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.genhosppsych.2020.05.009","volume":"67","author":"A Bahji","year":"2020","unstructured":"Bahji A, Reshetukha T, Newman A, et al. The Substance Treatment and Recovery Team (START): Measuring the effectiveness and feasibility of an inpatient addiction consult service at an academic general hospital. Gen Hosp Psychiatry. 2020;67:160-161. https:\/\/doi.org\/10.1016\/j.genhosppsych.2020.05.009.","journal-title":"Gen Hosp Psychiatry."},{"key":"8837_CR44","doi-asserted-by":"publisher","unstructured":"Deng H, Raheemullah A, Fenno LE, Lembke A. A telehealth inpatient addiction consult service is both feasible and effective in reducing readmission rates. J Addict Dis. Published online 2022. https:\/\/doi.org\/10.1080\/10550887.2022.2090822.","DOI":"10.1080\/10550887.2022.2090822"},{"issue":"March","key":"8837_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2017.12.043","volume":"186","author":"CD Nordeck","year":"2018","unstructured":"Nordeck CD, Welsh C, Schwartz RP, et al. Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service. Drug Alcohol Depend. 2018;186(March):23-28. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.12.043.","journal-title":"Drug Alcohol Depend."},{"key":"8837_CR46","doi-asserted-by":"publisher","unstructured":"Weinstein ZM, Cheng DM, D\u2019Amico MJ, et al. Inpatient addiction consultation and post-discharge 30-day acute care utilization. Drug Alcohol Depend. 2020;213. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108081.","DOI":"10.1016\/j.drugalcdep.2020.108081"},{"issue":"10","key":"8837_CR47","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s11606-021-07362-8","volume":"37","author":"JD Wilson","year":"2022","unstructured":"Wilson JD, Altieri Dunn SC, Roy P, Joseph E, Klipp S, Liebschutz J. Inpatient addiction medicine consultation service impact on post-discharge patient mortality: a propensity-matched analysis. J Gen Intern Med. 2022;37(10):2521-2525. https:\/\/doi.org\/10.1007\/s11606-021-07362-8.","journal-title":"J Gen Intern Med."},{"issue":"2","key":"8837_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/ajad.13000","volume":"29","author":"J Suzuki","year":"2020","unstructured":"Suzuki J, Robinson D, Mosquera M, et al. Impact of medications for opioid use disorder on discharge against medical advice among people who inject drugs hospitalized for infective endocarditis. Am J Addict. 2020;29(2):155-159. https:\/\/doi.org\/10.1111\/ajad.13000.","journal-title":"Am J Addict."},{"key":"8837_CR49","doi-asserted-by":"publisher","unstructured":"Chan HAC, Palepu A, Guh DP, et al. HIV-positive injection drug users who leave the hospital against medical advice the mitigating role of methadone and social support. J Acquir Immune Defic Syndr. 2004;35(1):56-59. https:\/\/doi.org\/10.1097\/00126334-200401010-00008.","DOI":"10.1097\/00126334-200401010-00008"},{"key":"8837_CR50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1081\/ADA-120037390","volume":"30","author":"P Green","year":"2004","unstructured":"Green P, Watts D, Dhopesh V. Why patients sign out against medical advice (AMA): Factors motivating patients to sign out AMA. Am J Drug Alcohol Abuse. 2004;30:489-493. https:\/\/doi.org\/10.1081\/ADA-120037390.","journal-title":"Am J Drug Alcohol Abuse."},{"issue":"5","key":"8837_CR51","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11606-021-06849-8","volume":"37","author":"SL Calcaterra","year":"2022","unstructured":"Calcaterra SL, McBeth L, Keniston AM, Burden M. The development and implementation of a hospitalist-directed addiction medicine consultation service to address a treatment gap. J Gen Intern Med. 2022;37(5):1065-1072. https:\/\/doi.org\/10.1007\/s11606-021-06849-8.","journal-title":"J Gen Intern Med."},{"issue":"3","key":"8837_CR52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/ajad.12349","volume":"25","author":"J Suzuki","year":"2016","unstructured":"Suzuki J. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis. Am J Addict. 2016;25(3):191-194. https:\/\/doi.org\/10.1111\/ajad.12349.","journal-title":"Am J Addict."},{"issue":"12","key":"8837_CR53","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","volume":"34","author":"H Englander","year":"2019","unstructured":"Englander H, Dobbertin K, Lind BK, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34(12):2796-2803. https:\/\/doi.org\/10.1007\/s11606-019-05251-9.","journal-title":"J Gen Intern Med."},{"issue":"4","key":"8837_CR54","doi-asserted-by":"publisher","first-page":"E257","DOI":"10.1097\/ADM.0000000000000939","volume":"16","author":"T Rosic","year":"2022","unstructured":"Rosic T, Naji L, Sanger N, et al. Factors associated with increased opioid use during the COVID-19 pandemic: a prospective study of patients enrolled in opioid agonist treatment. J Addict Med. 2022;16(4):E257-E264. https:\/\/doi.org\/10.1097\/ADM.0000000000000939.","journal-title":"J Addict Med."},{"key":"8837_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","volume":"164","author":"H Hansen","year":"2016","unstructured":"Hansen H, Siegel C, Wanderling J, DiRocco D. Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. Drug Alcohol Depend. 2016;164:14-21. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.03.028.","journal-title":"Drug Alcohol Depend."},{"key":"8837_CR56","doi-asserted-by":"publisher","unstructured":"Schuler MS, Dick AW, Stein BD. Growing racial\/ethnic disparities in buprenorphine distribution in the United States, 2007\u20132017. Drug Alcohol Depend. 2021;223. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108710.","DOI":"10.1016\/j.drugalcdep.2021.108710"},{"issue":"4","key":"8837_CR57","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ajhp\/zxaa408","volume":"78","author":"TH Tran","year":"2021","unstructured":"Tran TH, Swoboda H, Perticone K, et al. The substance use intervention team: A hospital-based intervention and outpatient clinic to improve care for patients with substance use disorders. Am J Health-Syst Pharm. 2021;78(4):345-353. https:\/\/doi.org\/10.1093\/ajhp\/zxaa408.","journal-title":"Am J Health-Syst Pharm."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-08837-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-08837-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-08837-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T12:07:28Z","timestamp":1732018048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-08837-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":57,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["8837"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-08837-0","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"The authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}}]}}